Polymersomes as a potential platform for cancer immunotherapy

Mellman, 2011, Cancer immunotherapy comes of age, Nature, 480, 480, 10.1038/nature10673 Ribas, 2018, Cancer immunotherapy using checkpoint blockade, Science, 359, 1350, 10.1126/science.aar4060 June, 2018, CAR T cell immunotherapy for human cancer, Science, 359, 1361, 10.1126/science.aar6711 Lesterhuis, 2011, Cancer immunotherapy--revisited, Nat. Rev. Drug Discov., 10, 591, 10.1038/nrd3500 June, 2017, Is autoimmunity the Achilles' heel of cancer immunotherapy?, Nat. Med., 23, 540, 10.1038/nm.4321 Goldberg, 2019, Improving cancer immunotherapy through nanotechnology, Nat. Rev. Cancer, 19, 587, 10.1038/s41568-019-0186-9 Riley, 2019, Delivery technologies for cancer immunotherapy, Nat. Rev. Drug Discov., 18, 175, 10.1038/s41573-018-0006-z Irvine, 2020, Enhancing cancer immunotherapy with nanomedicine, Nat. Rev. Immunol., 20, 321, 10.1038/s41577-019-0269-6 Martin, 2020, Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges, Nat. Rev. Clin. Oncol., 17, 251, 10.1038/s41571-019-0308-z Davis, 2008, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat. Rev. Drug Discov., 7, 771, 10.1038/nrd2614 Barenholz, 2012, Doxil®--the first FDA-approved nano-drug: lessons learned, J. Contr. Release, 160, 117, 10.1016/j.jconrel.2012.03.020 Jain, 2010, Delivering nanomedicine to solid tumors, Nat. Rev. Clin. Oncol., 7, 653, 10.1038/nrclinonc.2010.139 Petros, 2010, Strategies in the design of nanoparticles for therapeutic applications, Nat. Rev. Drug Discov., 9, 615, 10.1038/nrd2591 Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol., 33, 941, 10.1038/nbt.3330 Zhao, 2019, Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers, Adv. Drug Deliv. Rev., 143, 3, 10.1016/j.addr.2019.01.002 Sofias, 2021, A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system, Drug Discov. Today, 26, 1482, 10.1016/j.drudis.2021.02.017 Discher, 2002, Polymer vesicles, Science, 297, 967, 10.1126/science.1074972 Discher, 2006, Polymersomes, Annu. Rev. Biomed. Eng., 8, 323, 10.1146/annurev.bioeng.8.061505.095838 Leong, 2018, Engineering polymersomes for diagnostics and therapy, Adv. Healthc. Mater., 7, 10.1002/adhm.201701276 Shields, 2020, Materials for immunotherapy, Adv. Mater., 32, 10.1002/adma.201901633 Rideau, 2018, Liposomes and polymersomes: a comparative review towards cell mimicking, Chem. Soc. Rev., 47, 8572, 10.1039/C8CS00162F Anselmo, 2021, Nanoparticles in the clinic: an update post COVID-19 vaccines, Bioeng. Transl. Med., 6, 10.1002/btm2.10246 Matoori, 2020, Twenty-five years of polymersomes: lost in translation?, Mater. Horizons, 7, 1297, 10.1039/C9MH01669D Duivenvoorden, 2019, Nanoimmunotherapy to treat ischaemic heart disease, Nat. Rev. Cardiol., 16, 21, 10.1038/s41569-018-0073-1 Cifuentes-Rius, 2021, Inducing immune tolerance with dendritic cell-targeting nanomedicines, Nat. Nanotechnol., 16, 37, 10.1038/s41565-020-00810-2 Chen, 2013, Oncology meets immunology: the cancer-immunity cycle, Immunity, 39, 1, 10.1016/j.immuni.2013.07.012 Waldman, 2020, A guide to cancer immunotherapy: from T cell basic science to clinical practice, Nat. Rev. Immunol., 20, 651, 10.1038/s41577-020-0306-5 Labani-Motlagh, 2020, The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses, Front. Immunol., 11, 10.3389/fimmu.2020.00940 Schreiber, 2011, Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion, Science, 331, 1565, 10.1126/science.1203486 O'Donnell, 2019, Cancer immunoediting and resistance to T cell-based immunotherapy, Nat. Rev. Clin. Oncol., 16, 151, 10.1038/s41571-018-0142-8 Kubli, 2021, Beyond immune checkpoint blockade: emerging immunological strategies, Nat. Rev. Drug Discov., 20, 10.1038/s41573-021-00155-y Hiam-Galvez, 2021, Systemic immunity in cancer, Nat. Rev. Cancer, 21, 345, 10.1038/s41568-021-00347-z Wu, 2020, Generation of myeloid cells in cancer: the spleen matters, Front. Immunol., 11 Chen, 2021, Nanobiomaterial-based vaccination immunotherapy of cancer, Biomaterials, 270, 10.1016/j.biomaterials.2021.120709 Gong, 2021, Nanomaterials for T-cell cancer immunotherapy, Nat. Nanotechnol., 16, 25, 10.1038/s41565-020-00822-y Isser, 2021, Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy, Biomaterials, 268, 10.1016/j.biomaterials.2020.120584 Kim, 2021, Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy, J. Contr. Release, 332, 109, 10.1016/j.jconrel.2021.02.002 Sahin, 2018, Personalized vaccines for cancer immunotherapy, Science, 359, 1355, 10.1126/science.aar7112 Rosenberg, 2015, Adoptive cell transfer as personalized immunotherapy for human cancer, Science (80-.), 348, 62, 10.1126/science.aaa4967 Kumar, 2017, Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy, Front. Pharmacol., 8 Demaria, 2019, Harnessing innate immunity in cancer therapy, Nature, 574, 45, 10.1038/s41586-019-1593-5 Mulder, 2019, Therapeutic targeting of trained immunity, Nat. Rev. Drug Discov., 18, 553, 10.1038/s41573-019-0025-4 Wong, 2019, Non-spherical polymersomes: formation and characterization, Chem. Soc. Rev., 48, 4019, 10.1039/C8CS00856F Lefley, 2020, Macromolecular design and preparation of polymersomes, Polym. Chem., 11, 7124, 10.1039/D0PY01247E Iqbal, 2020, Polymersomes for therapeutic delivery of protein and nucleic acid macromolecules: from design to therapeutic applications, Biomacromolecules, 21, 1327, 10.1021/acs.biomac.9b01754 Williams, 2017, Controlling the morphology of copolymeric vectors for next generation nanomedicine, J. Contr. Release, 259, 29, 10.1016/j.jconrel.2017.02.030 Che, 2016, Stimuli-responsive polymersomes and nanoreactors, J. Mater. Chem. B, 4, 4632, 10.1039/C6TB01163B Miller, 2021, Probing and tuning the permeability of polymersomes, ACS Cent. Sci., 7, 30, 10.1021/acscentsci.0c01196 Men, 2016, Methods for production of uniform small-sized polymersome with rigid membrane, Polym. Chem., 7, 3977, 10.1039/C6PY00668J Bartenstein, 2016, Stability of polymersomes prepared by size exclusion chromatography and extrusion, Colloids Surf. A Physicochem. Eng. Asp., 506, 739, 10.1016/j.colsurfa.2016.07.032 Allen, 2017, Facile assembly and loading of theranostic polymersomes via multi-impingement flash nanoprecipitation, J. Contr. Release, 262, 91, 10.1016/j.jconrel.2017.07.026 Brinkhuis, 2012, Size dependent biodistribution and SPECT imaging of (111)In-labeled polymersomes, Bioconjugate Chem., 23, 958, 10.1021/bc200578s Discher, 1999, Polymersomes: tough vesicles made from diblock copolymers, Science, 284, 1143, 10.1126/science.284.5417.1143 Yi, 2016, Tailoring nanostructure morphology for enhanced targeting of dendritic cells in atherosclerosis, ACS Nano, 10, 11290, 10.1021/acsnano.6b06451 Dowling, 2017, Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses, J. Allergy Clin. Immunol., 140, 1339, 10.1016/j.jaci.2016.12.985 Allen, 2018, Polymersomes scalably fabricated via flash nanoprecipitation are non-toxic in non-human primates and associate with leukocytes in the spleen and kidney following intravenous administration, Nano Res., 11, 5689, 10.1007/s12274-018-2069-x de Kruijff, 2019, Elucidating the influence of tumor presence on the polymersome circulation time in mice, Pharmaceutics, 11, 10.3390/pharmaceutics11050241 Mulder, 2018, High-density lipoprotein nanobiologics for precision medicine, Acc. Chem. Res., 51, 127, 10.1021/acs.accounts.7b00339 Braza, 2018, Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance, Immunity, 49, 819, 10.1016/j.immuni.2018.09.008 Priem, 2020, Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition, Cell, 183, 786, 10.1016/j.cell.2020.09.059 van Leent, 2021, A modular approach toward producing nanotherapeutics targeting the innate immune system, Sci. Adv., 7, 10.1126/sciadv.abe7853 Najibi, 2020, Cell and tissue engineering in lymph nodes for cancer immunotherapy, Adv. Drug Deliv. Rev., 161–162, 42, 10.1016/j.addr.2020.07.023 Chen, 2020, Engineering strategies for lymph node targeted immune activation, Acc. Chem. Res., 53, 2055, 10.1021/acs.accounts.0c00260 Schudel, 2019, Material design for lymph node drug delivery, Nat. Rev. Mater., 4, 415, 10.1038/s41578-019-0110-7 Du, 2017, Immunotheranostic polymersomes modularly assembled from tetrablock and diblock copolymers with oxidation-responsive fluorescence, Cell. Mol. Bioeng., 10, 357, 10.1007/s12195-017-0486-7 Fooksman, 2010, Functional anatomy of T cell activation and synapse formation, Annu. Rev. Immunol., 28, 79, 10.1146/annurev-immunol-030409-101308 Lillemeier, 2010, TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation, Nat. Immunol., 11, 90, 10.1038/ni.1832 Eggermont, 2014, Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells, Trends Biotechnol., 32, 456, 10.1016/j.tibtech.2014.06.007 Van Der Weijden, 2014, The right touch: design of artificial antigen-presenting cells to stimulate the immune system, Chem. Sci., 5, 3355, 10.1039/C4SC01112K Perica, 2015, Linking form to function: biophysical aspects of artificial antigen presenting cell design, Biochim. Biophys. Acta, 1853, 781, 10.1016/j.bbamcr.2014.09.001 Rhodes, 2018, Nanoscale artificial antigen presenting cells for cancer immunotherapy, Mol. Immunol., 98, 13, 10.1016/j.molimm.2018.02.016 Mandal, 2014, Polymer-based synthetic dendritic cells for tailoring robust and multifunctional T cell responses, ACS Chem. Biol., 10, 485, 10.1021/cb500455g Hammink, 2017, Controlling T-cell activation with synthetic dendritic cells using the multivalency effect, ACS Omega, 2, 937, 10.1021/acsomega.6b00436 Abdelmohsen, 2016, formation of well-defined, functional nanotubes via osmotically induced shape transformation of biodegradable polymersomes, J. Am. Chem. Soc., 138, 9353, 10.1021/jacs.6b03984 Wauters, 2019, Development of morphologically discrete PEG-PDLLA nanotubes for precision nanomedicine, Biomacromolecules, 20, 177, 10.1021/acs.biomac.8b01245 Meyer, 2015, Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation, Small, 11, 1519, 10.1002/smll.201402369 Pawar, 2013, Functionalized polymersomes for biomedical applications, Polym. Chem., 4, 3160, 10.1039/c3py00023k Dawson, 2021, Current understanding of biological identity at the nanoscale and future prospects, Nat. Nanotechnol., 16, 229, 10.1038/s41565-021-00860-0 Photos, 2003, Polymer vesicles in vivo: correlations with PEG molecular weight, J. Contr. Release, 90, 323, 10.1016/S0168-3659(03)00201-3 Vincent, 2021, The combination of morphology and surface chemistry defines the immunological identity of nanocarriers in human blood, Adv. Ther., 4 Scherer, 2016, Functionalization of active ester-based polymersomes for enhanced cell uptake and stimuli-responsive cargo release, Biomacromolecules, 17, 3305, 10.1021/acs.biomac.6b01049 Zhu, 2019, Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination, Biomaterials, 206, 25, 10.1016/j.biomaterials.2019.03.012 Kulkarni, 2016, Mitochondria-targeted fluorescent polymersomes for drug delivery to cancer cells, Polym. Chem., 7, 4151, 10.1039/C6PY00623J Anajafi, 2017, Nuclear localizing peptide-conjugated, redox-sensitive polymersomes for delivering curcumin and doxorubicin to pancreatic cancer microtumors, Mol. Pharm., 14, 1916, 10.1021/acs.molpharmaceut.7b00014 Zelmer, 2020, Organelle-specific targeting of polymersomes into the cell nucleus, Proc. Natl. Acad. Sci. U.S.A., 117, 2770, 10.1073/pnas.1916395117 Tacken, 2007, Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting, Nat. Rev. Immunol., 7, 790, 10.1038/nri2173 Volpatti, 2021, Polymersomes decorated with the SARS-CoV-2 spike protein receptor-binding domain elicit robust humoral and cellular immunity, ACS Cent. Sci., 7, 1368, 10.1021/acscentsci.1c00596 Stano, 2013, Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles, Biomaterials, 34, 4339, 10.1016/j.biomaterials.2013.02.024 Rincon-Restrepo, 2017, Vaccine nanocarriers: coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses, Biomaterials, 132, 48, 10.1016/j.biomaterials.2017.03.047 Zupančič, 2017, Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming, J. Contr. Release, 258, 182, 10.1016/j.jconrel.2017.05.014 Hashimoto-Tane, 2016, Dynamic regulation of TCR-microclusters and the microsynapse for T cell activation, Front. Immunol., 7, 10.3389/fimmu.2016.00255 Fuertes Marraco, 2012, A stepwise protocol to coat aAPC beads prevents out-competition of anti-CD3 mAb and consequent experimental artefacts, J. Immunol. Methods, 385, 90, 10.1016/j.jim.2012.07.017 Rijpkema, 2020, Modular approach to the functionalization of polymersomes, Biomacromolecules, 21, 1853, 10.1021/acs.biomac.9b01734 Hu, 2016, Towards the next generation of biomedicines by site-selective conjugation, Chem. Soc. Rev., 45, 1691, 10.1039/C4CS00388H Prakken, 2000, Artificial antigen-presenting cells as a tool to exploit the immune ‘synapse’, Nat. Med., 6, 1406, 10.1038/82231 Giannoni, 2005, Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane, J. Immunol., 174, 3204, 10.4049/jimmunol.174.6.3204 Zappasodi, 2008, The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells, Haematologica, 93, 1523, 10.3324/haematol.12521 Itel, 2014, Molecular organization and dynamics in polymersome membranes: a lateral diffusion study, Macromolecules, 47, 7588, 10.1021/ma5015403 Lopresti, 2011, Controlling polymersome surface topology at the nanoscale by membrane confined polymer/polymer phase separation, ACS Nano, 5, 1775, 10.1021/nn102455z Ruiz-Pérez, 2016, Molecular engineering of polymersome surface topology, Sci. Adv., 2, 10.1126/sciadv.1500948 Aibani, 2019, Liposome mimicking polymersomes; A comparative study of the merits of polymersomes in terms of formulation and stability, Int. J. Pharm., X 2 Hou, 2021, Lipid nanoparticles for mRNA delivery, Nat. Rev. Mater., 6, 1078, 10.1038/s41578-021-00358-0 Liu, 2010, The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes, Biomaterials, 31, 7575, 10.1016/j.biomaterials.2010.06.021 Xu, 2019, Efficient and targeted drug/siRNA co-delivery mediated by reversibly crosslinked polymersomes toward anti-inflammatory treatment of ulcerative colitis (UC), Nano Res., 12, 659, 10.1007/s12274-019-2274-2 Xia, 2021, Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma, J. Contr. Release, 336, 262, 10.1016/j.jconrel.2021.06.032 Welzen, 2021, Reversibly self-assembled pH-responsive PEG-p(CL-g-TMC) polymersomes, J. Polym. Sci., 59, 1241 Meng, 2003, Biodegradable Polymersomes. Macromolecules, 36, 3004 Sui, 2015, Robust formation of biodegradable polymersomes by direct hydration, Polym. Chem., 6, 691, 10.1039/C4PY01288G Schatz, 2009, Polysaccharide-block-polypeptide copolymer vesicles: towards synthetic viral capsids, Angew. Chem. Int. Ed., 48, 2572, 10.1002/anie.200805895 Sanson, 2010, Biocompatible and biodegradable poly(trimethylene carbonate)-b-Poly (L-glutamic acid) polymersomes: size control and stability, Langmuir, 26, 2751, 10.1021/la902786t Ahmed, 2004, Self-porating polymersomes of PEG–PLA and PEG–PCL: hydrolysis-triggered controlled release vesicles, J. Contr. Release, 96, 37, 10.1016/j.jconrel.2003.12.021 Scott, 2012, Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes, Biomaterials, 33, 6211, 10.1016/j.biomaterials.2012.04.060 Gao, 2018, Effective intracellular delivery and Th1 immune response induced by ovalbumin loaded in pH-responsive polyphosphazene polymersomes, Nanomedicine, 14, 1609, 10.1016/j.nano.2018.04.001 Shae, 2019, Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy, Nat. Nanotechnol., 14, 269, 10.1038/s41565-018-0342-5 Shae, 2020, Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines, ACS Nano, 14, 9904, 10.1021/acsnano.0c02765 Wehbe, 2021, Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration, J. Contr. Release, 330, 1118, 10.1016/j.jconrel.2020.11.017 Jiang, 2020, cGAS-STING, an important pathway in cancer immunotherapy, J. Hematol. Oncol., 13, 81, 10.1186/s13045-020-00916-z Aval, 2020, Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy, J. Clin. Med., 9, 1 Wang, 2018, Dually gated polymersomes for gene delivery, Nano Lett., 18, 5562, 10.1021/acs.nanolett.8b01985 Gumz, 2017, Fine-tuning the pH response of polymersomes for mimicking and controlling the cell membrane functionality, Polym. Chem., 8, 2904, 10.1039/C7PY00089H Zhang, 2020, Rapid generation of block copolymer libraries using automated chromatographic separation, J. Am. Chem. Soc., 142, 9843 Bobbala, 2021, Just add water: hydratable, morphologically diverse nanocarrier powders for targeted delivery, Nanoscale, 13, 11349, 10.1039/D1NR02188E